Clinical Trial Update: A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tapentadol (CG5503) for chronic tumor-related pain compared with placebo and morphine has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Pain
• Tumor-related Pain

Drugs mentioned

• Tapentadol (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Tumor, Pain | Phase 3 | Status: COMPLETED | Results posted: 2014-05-07